Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-Arm, Open, Multicenter, Exploratory Clinical Study of Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer (FAT-1)

NCT06539091 is registered in ClinicalTrials.gov with Anhui Provincial Hospital as lead sponsor.

NCT NCT06539091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06539091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-Arm, Open, Multicenter, Exploratory Clinical Study of Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer (FAT-1)
Lead sponsor
Anhui Provincial Hospital
Phase
Phase 3
Overall status
Not yet recruiting
Start date
October 1, 2024
Completion date
October 1, 2026
Enrollment
51 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bone mineral density, efficacy, epithelial ovarian cancer, safety, tolerability